By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Fiscal third-quarter revenues rose 22 percent year over year with its Life Sciences segment seeing 21 percent growth, Agilent Technologies reported after the close of the market on Monday.

For the three months ended July 31, total revenues came in at $1.69 billion, compared to $1.38 billion a year ago, beating analyst estimates of $1.66 billion. Orders for the quarter increased 13 percent to $1.69 billion from $1.49 billion a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.